Angioma Alliance
Angioma Alliance shows strong revenue growth and zero officer compensation over a decade.
EIN: 20600697 · Charlottesville, VA · NTEE: G80 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $1.4M |
| Total Expenses | $1.4M |
| Program Spending | 85% |
| CEO/Top Officer Pay | $1 |
| Net Assets | $1.1M |
| Transparency Score | 92/100 |
Is Angioma Alliance Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Angioma Alliance directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Angioma Alliance
Angioma Alliance (EIN: 20600697) is a nonprofit organization based in Charlottesville, VA, classified under NTEE code G80. The organization reported total revenue of $1.4M and total assets of $1.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Angioma Alliance's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Angioma Alliance is a mid-size nonprofit that has been operating for 24 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 17.9%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.3M |
| Total Expenses | $1.4M |
| Surplus / Deficit | $-77,247 |
| Total Assets | $1.1M |
| Total Liabilities | $32K |
| Net Assets | $1.1M |
| Operating Margin | -6.0% |
| Debt-to-Asset Ratio | 2.8% |
| Months of Reserves | 9.9 months |
Financial Health Grade: B
In 2023, Angioma Alliance reported a deficit of $77K with expenses exceeding revenue, holds 9.9 months of operating reserves (strong position), has a debt-to-asset ratio of 2.8% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Angioma Alliance's revenue has grown at a compound annual growth rate (CAGR) of 17.9%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +19.8% | +71.1% | -6.7% |
| 2022 | +29.8% | +84.5% | +33.3% |
| 2021 | +43.2% | -12.4% | +63.1% |
| 2020 | -14.7% | -18.3% | +30.2% |
| 2019 | +22.4% | +16.5% | +21.0% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2002 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Angioma Alliance with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, Angioma Alliance allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $77K, with expenses exceeding revenue.
- Debt-to-asset ratio: 2.8%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that officers are either uncompensated or compensated through non-officer roles, which is highly favorable for a nonprofit of its size with over $1 million in revenue.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Angioma Alliance's IRS 990 filings:
- Expenses slightly exceeded revenue in the 2023 filing ($1,369,269 vs. $1,292,022), which warrants monitoring to ensure it's not a recurring trend.
Strengths
The following positive indicators were identified for Angioma Alliance:
- Consistent and significant revenue growth over a decade, from $271,692 in 2014 to $1,292,022 in 2023.
- Zero officer compensation reported across all 13 filings, indicating strong financial transparency and dedication to mission.
- Healthy and growing asset base, increasing from $237,322 in 2014 to $1,134,529 in 2023.
- Low and stable liabilities, suggesting good financial management.
- Strong program focus implied by the absence of executive compensation.
Frequently Asked Questions about Angioma Alliance
Is Angioma Alliance a legitimate charity?
Angioma Alliance (EIN: 20600697) is a registered tax-exempt nonprofit based in Virginia. Our AI analysis gives it a Mission Score of 92/100. It has 13 years of IRS 990 filings on record. Total revenue: $1.4M. 1 red flag identified. 5 strengths noted. Financial health grade: B.
How does Angioma Alliance spend its money?
Angioma Alliance directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to Angioma Alliance tax-deductible?
Angioma Alliance is registered as a tax-exempt nonprofit (EIN: 20600697). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Angioma Alliance CEO make?
Angioma Alliance's highest-compensated officer earns $1 annually. The organization reported $1.4M in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Angioma Alliance's spending goes to programs?
Angioma Alliance directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Angioma Alliance compare to similar nonprofits?
With a transparency score of 92/100 (Excellent), Angioma Alliance is above average for NTEE category G80 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Angioma Alliance located?
Angioma Alliance is headquartered in Charlottesville, Virginia and files with the IRS under EIN 20600697. It is classified under NTEE code G80.
How many years of IRS 990 filings does Angioma Alliance have?
Angioma Alliance has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.4M in total revenue.
Is Angioma Alliance a good charity?
Based on the provided financial data, Angioma Alliance appears to be a very good charity. It demonstrates strong financial growth, healthy assets, low liabilities, and a remarkable commitment to transparency with 0% officer compensation reported for over a decade.
How has Angioma Alliance's revenue changed over time?
Angioma Alliance has experienced significant revenue growth, increasing from $271,692 in 2014 to $1,292,022 in 2023, indicating growing support and impact.
What is Angioma Alliance's approach to executive compensation?
Angioma Alliance reports 0% officer compensation in all available filings, suggesting a highly efficient and mission-focused approach where leadership is either volunteer or compensated through other means, ensuring funds are directed to programs.
Are Angioma Alliance's assets growing?
Yes, Angioma Alliance's assets have shown consistent growth, increasing from $237,322 in 2014 to $1,134,529 in 2023, indicating financial stability and capacity.
Filing History
IRS 990 filing history for Angioma Alliance showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Angioma Alliance's revenue has grown by 623.2%, moving from $179K to $1.3M. Total assets increased by 616% over the same period, from $158K to $1.1M. Total functional expenses rose by 649.6%, from $183K to $1.4M. In its most recent filing year (2023), Angioma Alliance reported a deficit of $77K, with expenses exceeding revenue. The organization holds $32K in liabilities against $1.1M in assets (debt-to-asset ratio: 2.8%), resulting in net assets of $1.1M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.3M | $1.4M | $1.1M | $32K | — | View 990 |
| 2022 | $1.1M | $800K | $1.2M | $36K | — | View 990 |
| 2021 | $831K | $434K | $912K | $15K | — | View 990 |
| 2020 | $580K | $495K | $559K | $63K | — | View 990 |
| 2019 | $679K | $605K | $429K | $22K | — | View 990 |
| 2018 | $555K | $520K | $355K | $22K | — | View 990 |
| 2017 | $455K | $420K | $320K | $22K | — | View 990 |
| 2016 | $306K | $320K | $283K | $20K | — | View 990 |
| 2015 | $355K | $301K | $310K | $32K | — | View 990 |
| 2014 | $272K | $264K | $237K | $14K | — | View 990 |
| 2013 | $273K | $228K | $220K | $4K | — | View 990 |
| 2012 | $219K | $201K | $179K | $9K | — | View 990 |
| 2011 | $179K | $183K | $158K | $7K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.3M, expenses of $1.4M, and assets of $1.1M (revenue +19.8% year-over-year).
- 2022: Revenue of $1.1M, expenses of $800K, and assets of $1.2M (revenue +29.8% year-over-year).
- 2021: Revenue of $831K, expenses of $434K, and assets of $912K (revenue +43.2% year-over-year).
- 2020: Revenue of $580K, expenses of $495K, and assets of $559K (revenue -14.7% year-over-year).
- 2019: Revenue of $679K, expenses of $605K, and assets of $429K (revenue +22.4% year-over-year).
- 2018: Revenue of $555K, expenses of $520K, and assets of $355K (revenue +22.1% year-over-year).
- 2017: Revenue of $455K, expenses of $420K, and assets of $320K (revenue +48.5% year-over-year).
- 2016: Revenue of $306K, expenses of $320K, and assets of $283K (revenue -13.9% year-over-year).
- 2015: Revenue of $355K, expenses of $301K, and assets of $310K (revenue +30.8% year-over-year).
- 2014: Revenue of $272K, expenses of $264K, and assets of $237K (revenue -0.6% year-over-year).
- 2013: Revenue of $273K, expenses of $228K, and assets of $220K (revenue +24.7% year-over-year).
- 2012: Revenue of $219K, expenses of $201K, and assets of $179K (revenue +22.7% year-over-year).
- 2011: Revenue of $179K, expenses of $183K, and assets of $158K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Angioma Alliance:
Data Sources and Methodology
This transparency report for Angioma Alliance is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.